Loading company…
ID 405335944 · FY 2020–2024 · 5 years
1.2 კომპანიის ძირითად საქმიანობას წარმოადგენს: - საბითუმო ვაჭრობა ფარმაცევტული საქონლითთავისუფალ ინდუსტრიულ ზონაში 1.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|
| Total Revenue | 2,190 | 6,230 | 7,488 | 6,939 | 8,314 | +39.6% |
| Total COGS | -1,588 | -3,620 | -3,975 | -4,343 | -5,026 | +33.4% |
| Gross Profit | 602 | 2,610 | 3,514 | 2,596 | 3,289 | +52.9% |
| Gross Margin | 27.5% | 41.9% | 46.9% | 37.4% | 39.6% | |
| Total Operating Expenses | -625 | -750 | -337 | -297 | -225 | -22.5% |
| EBITDA | -23 | 1,860 | 3,177 | 2,299 | 3,063 | nmf |
| EBITDA Margin | -1.0% | 29.9% | 42.4% | 33.1% | 36.8% | |
| Total D&A | -5 | -7 | -12 | 0 | -11 | +20.6% |
| EBIT / Operating Income | -28 | 1,853 | 3,165 | 2,299 | 3,053 | nmf |
| Total Other Income | 207 | -14 | -152 | -173 | 19 | -44.8% |
| Profit Before Tax | 180 | 1,839 | 3,013 | 2,127 | 3,072 | +103.4% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 180 | 1,839 | 3,009 | 2,127 | 3,072 | +103.4% |
| Net Margin | 8.2% | 29.5% | 40.2% | 30.6% | 36.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.